Dopamine formation from tyramine by CYP2D6

Biochemical and Biophysical Research Communications

Volumn 249, Issue 3, 1998, Pages 838-843

  Hiroi, Toyoko ^a   Imaoka, Susumu ^a   Funae, Yoshihiko ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Catecholamine; CYP2D6; Dopamine; Oxidation; Tyramine

Indexed keywords

ANTISERUM; CYTOCHROME P450 ISOENZYME; DOPAMINE; TYRAMINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL TISSUE; ARTICLE; DOPAMINE METABOLISM; EXPRESSION VECTOR; HUMAN; HYDROXYLATION; LIVER MICROSOME; MICHAELIS CONSTANT; NONHUMAN; PRIORITY JOURNAL; RAT; YEAST;

ANIMALIA;

EID: 0032575505     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1998.9232     Document Type: Article

References (34)

1. Carlsson A. Pharmacol. Rev. 11:1959;490-493.
2. Dahlstrom A., Fuxe K. Acta Physiol. Scand. 232:1993;1-55.
3. Lindvall O., Bjorklund A. Chemical Neuroanatomy. 1983;Raven Press, New York. p. 229-255.
4. Seeman P., Guan H.-C., Van Tol H. H. M. Nature. 365:1993;441-445.
5. Amenta F. Clin. Exp. Hypertens. 19:1997;27-41.
6. Ricci A., Mariotta S., Greco S., Bisetti A. Clin. Exp. Hypertens. 19:1997;59-71.
7. Aperia A., Eklof A.-C., Holtback U., Nowicki S., Sundelof M., Greengard P. Adv. Pharmacol. 42:1998;870-873.
8. Udenfriend S., Wyngaarden J. B. Biochim. Biophys. Acta. 20:1956;48-52.
9. Axelrod J. Science. 144:1963;499-500.
10. Lemberger L., Kuntzman R., Conney A. H., Burns J. J. J. Pharmacol. Exp. Ther. 150:1965;292-297.
11. Jonsson J., Lindeke B., Cho A. K. Acta Pharmacol. Toxicol. 37:1975;352-360.
12. Funae Y., Imaoka S. Biochim. Biophys. Acta. 842:1985;119-132.
13. Imaoka S., Yamada T., Hiroi T., Hayashi K., Sakaki T., Yabusaki Y., Funae Y. Biochem. Pharmacol. 51:1996;1041-1050.
14. Wan J., Imaoka S., Chow T., Hiroi T., Yabusaki Y., Funae Y. Arch. Biochem. Biophys. 348:1997;383-390.
15. Ohishi N., Imaoka S., Suzuki T., Funae Y. Biochim. Biophys. Acta. 1158:1993;227-236.
16. Mills M. H., Finlay D. C., Hadded P. R. J. Chromatography. 564:1991;93-102.
17. Funae Y., Imaoka S. Biochim. Biophys. Acta. 926:1987;349-358.
18. Ioannides C. Cytochromes P450: Metabolic and Toxicological Aspects. 1996;CRC Press, Boca Raton.
19. Gilham D. E., Cairns W., Paine M. J. I., Modi S., Poulsom R., Roberts G. C. K., Wolf C. R. Xenobiotica. 27:1997;111-125.
20. Crewe H. K., Lennard M. S., Tucjer G. T., Woods F. R., Haddock R. E. Br. J. Clin. Pharmac. 34:1992;262-265.
21. Martinez C., Agundez J. A. G., Gervasini G., Martin R., Benitez J. Pharmacogenetics. 7:1997;85-93.
22. Greenawalt J. W., Schnaitman C. J. Cell Biol. 46:1970;173-179.
23. Krueger M. J., Singer T. P. Anal. Biochem. 214:1993;116-123.
24. Boulton A. A., Baker G. B. J. Neurochem. 25:1975;477-481.
25. Andrew R., Best S. A., Watson D. G., Midgley J. M., Reid J. L., Squire I. B. Neurochem. Res. 18:1993;1179-1182.
26. Ibrahm K. E., Couch M. W., Williams C. M. Biochem. Med. 33:1985;53-59.
27. Musso N. R., Brenci S., Setti M., Indiveri F., Lotti G. J. Clin. Endocrinol. Metab. 81:1996;3553-3557.
28. McFadyen M. C. E., Melvin W. T., Murray G. I. Biochem. Pharmacol. 55:1998;625-830.
29. Bertilsson L., Alm C., De Las Carreras C., Widen J., Edman G., Schalling D. Lancet. ii:1989;555.
30. Llerena A., Edman G., Cobaleda J., Benitez J., Schalling D., Bertilsson L. Acta Psychiatr. Scand. 87:1993;23-28.
31. Philips S. R., Rozdilsky B., Boulton B. Biol. Psychiat. 13:1978;51-57.
32. Smith I., Kellow A. H. Nature. 221:1969;1261.
33. Juorio A. V. Gen. Pharmac. 13:1982;181-183.
34. Silkatis R. P., Monsnaim A. D. Brain Research. 114:1976;105-115.